EHIC [eHi Car Services] 6-K: (Original Filing)
[] []
EHIC [eHi Car Services] SC 13E3/A: (Original Filing)
[PROXY STATEMENT OF THE COMPANY March 11, 2019 Shareholders of eHi Car Services Limited Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: i The purpose of the extraordinary general meeting is for you and the other shareholders of the Company to consider and vote upon, amon]
EHIC [eHi Car Services] SC 13E3/A: PROXY STATEMENT OF THE COMPANY March 11, 2019
[PROXY STATEMENT OF THE COMPANY March 11, 2019 Shareholders of eHi Car Services Limited Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: i The purpose of the extraordinary general meeting is for you and the other shareholders of the Company to consider and vote upon, amon]
CCIH [ChinaCache International] 6-K: (Original Filing)
[ChinaCache International Holdings Ltd. Announces BEIJING — March 11, 2019 First Nine Months of 2018 Financial Overview · Net revenues · Gross profit · Net income · Adjusted EBITDA In the first nine months of 2018, our strategy focused on core CDN services and related business, which is the main driv]
CCIH [ChinaCache International] 6-K: ChinaCache International Holdings Ltd. Announces BEIJING — March
[ChinaCache International Holdings Ltd. Announces BEIJING — March 11, 2019 First Nine Months of 2018 Financial Overview · Net revenues · Gross profit · Net income · Adjusted EBITDA In the first nine months of 2018, our strategy focused on core CDN services and related business, which is the main driv]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
CXDC [China XD Plastics Co] 8-K: (Original Filing)
[] [Item 3.03 Material Modification to Rights of Security Holders. Company Amended and Restated Certificate Amendment of the Series D Certificate of Designation On March 11, 2019, the board of directors of China XD Plastics Company Limited (the “ (d) 3.1 Amendment of the Series D Certificate of Desig]
SVA [SINOVAC BIOTECH] 6-K: Sinovac: Sinovac Update on the Exchange of Rights
[Sinovac: Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares March 8, 2019 BEIJING, – Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today issued an update on the Exchange of Rights for Common ]
CXDC [China XD Plastics Co] 8-K:
[] [Item 3.03 Material Modification to Rights of Security Holders. Company Amended and Restated Certificate Amendment of the Series D Certificate of Designation On March 11, 2019, the board of directors of China XD Plastics Company Limited (the “ (d) 3.1 Amendment of the Series D Certificate of Desig]
